Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Valeric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.89 |
| ▸ | CES1 | P23141 | 3/20 | 0.63 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.63 |
| ▸ | CES2 | O00748 | 2/20 | 0.63 |
| ▸ | FABP3 | P05413 | 6/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valeric Acid SCHEMBL29364939 | 0.97 | CA1 (0.94) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL29157748 | 0.97 | CA1 (0.94) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL11815174 | 0.97 | CA1 (0.94) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL673168 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL2208751 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL6916047 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL11425588 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL150677 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL9419811 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL9127460 | 0.94 | CA1 (0.89) | CA1CES1FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12439945-B2 | Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol and use as a nutritional supplement and therapeutic agent | VitaNav, Inc. (US) | 2025-10-14 | — | — | US | claimed |
| CN-119968132-A | Acid and salt compound and preparation method thereof | 南京纽邦生物科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| WO-2025060941-A1 | METHOD FOR PRODUCING POLYHYDROXYALKANOATE | 清华大学 | 2025-03-27 | — | — | WO | claimed |
| CN-113683577-B | Synthesis method of hexamethylene diisocyanate trimer | 宁夏瑞泰科技股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2024067626-A1 | COMPOSITE OF ACID AND SALT, AND PREPARATION METHOD THEREFOR | 南京纽邦生物科技有限公司 | 2024-04-04 | — | — | WO | claimed |
| CN-116970659-B | Method for producing polyhydroxyalkanoate | 清华大学 | 2024-02-09 | — | — | CN | claimed |
| US-11850294-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2023-12-26 | — | — | US | claimed |
| US-20230118672-A1 | SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-04-20 | — | — | US | claimed |
| US-11529295-B2 | Oral care composition | CHURCH & DWIGHT CO., INC. (US) | 2022-12-20 | — | — | US | claimed |
| EP-4034072-A2 | ORAL CARE COMPOSITION | Church & Dwight Co., Inc. (US) | 2022-08-03 | — | — | EP | claimed |
| US-20070281056-A1 | Premixes, Flour Enriched With Same, Mineral Supplemented Foodstuffs And Methods Of Manufacture Thereof | NUTRACEUTICALS LIMITED (GB) | 2007-12-06 | — | — | US | claimed |
| EP-1791433-A2 | PREMIX COMPRISING CALCIUM AND VITAMIN D, FLOUR ENRICHED WITH SAME UND BREAD PRODUCT THEREFROM | Nutraceuticals Limited (GB) | 2007-06-06 | — | — | EP | claimed |
| WO-2006016170-A2 | PREMIXES, FLOUR ENRICHED WITH SAME, MINERAL SUPPLEMENTED FOODSTUFF AND METHODS OF MANUFACTURE THEREOF | NUTRACEUTICALS LIMITED (GB) | 2006-02-16 | — | — | WO | claimed |
| US-20040192589-A1 | Production of high molecular mass lectins | ENZON PHARMACEUTICALS, INC | 2004-09-30 | — | — | US | claimed |
| EP-1412377-A1 | PRODUCTION OF HIGH MOLECULAR MASS LECTINS | Natimmune A/S (DK) | 2004-04-28 | — | — | EP | claimed |
| WO-2003010188-A1 | PRODUCTION OF HIGH MOLECULAR MASS LECTINS | NATIMMUNE A/S (DK) | 2003-02-06 | — | — | WO | claimed |
| US-6303104-B1 | FIRST DISCRETE PART COMPRISING A WATER-SOLUBLE OR PARTIALLY WATER-SOLUBLE CALCIUM SALT, AND A SECOND DISCRETE PART COMPRISING A WATER-SOLUBLE ORTHOPHOSPHATE SALT AND SODIUM GLUCONATE | ENAMELON, INC. | 2001-10-16 | — | — | US | claimed |
| WO-2000047173-A1 | REMINERALIZING/MINERALIZING ORAL PRODUCTS HAVING IMPROVED WHITENING AND STAIN REMOVAL PROPERTIES | ENAMELON, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| US-5945144-A | PASTA PRODUCT SUCH AS MACRONI CONSISTS OF WHEAT FLOUR, WATER, CALCIUM INORGANIC AND ORGANIC SALTS; AN IMPORTANT SOURCE OF CALCIUM TO AVOID OSTEOPOROSIS AND BONE SOFTNESS | NEW WORLD PASTA COMPANY | 1999-08-31 | — | — | US | claimed |
| US-4232740-A | High temperature stable sand control method | TEXACO DEVELOPMENT CORP. (US) | 1980-11-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118672-A1 | SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION | DECR2, DECR1, C9 | CA1 2268/4885CES1 1161/4885FFAR3 79/4885 |
| US-11850294-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | CA1 329/4885CES1 724/4885FFAR3 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.